CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Teva Pharmaceutical Industries Limited Company Snapshot
Teva Pharmaceutical Industries Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Teva Pharmaceutical Industries Limited with three other pharmaceutical manufacturers in Middle East: Saudi Pharmaceutical Industries & Medical Appliances Corporation of Saudi Arabia (2016 sales of 1.84 billion Saudi Riyals [US$490.99 million] of which 100% was Pharmaceutical and Medical Manufacturing), Enzymotec Ltd (182.39 million Israel Shekels [US$50.19 million] ), and Taro Pharmaceutical Industries Ltd (3.67 billion Israel Shekels [US$1.01 billion] ).

Sales Analysis. Teva Pharmaceutical Industries Limited reported sales of 83.76 billion Israel Shekels (US$23.05 billion) for the year ending December of 2016. This represents an increase of 9.7% versus 2015, when the company's sales were 76.37 billion Israel Shekels. Sales of Generic Madicines saw an increase that was more than double the company's growth rate: sales were up 23.6% in 2016, from 37.10 billion Israel Shekels to 45.85 billion Israel Shekels. Not all segments of Teva Pharmaceutical Industries Limited experienced an increase in sales in 2016: sales of Other fell 31.0% to 4.74 billion Israel Shekels.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Teva Pharmaceutical Industries Limited
  Stock Performance Chart for Teva Pharmaceutical Industries Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2017): 122.10
(Figures in Israel Shekels)
1 Week 0.7%   13 Weeks -8.8%  
4 Weeks -14.3%   52 Weeks -42.6%  
 
Teva Pharmaceutical Industries Limited Key Data:
  Ticker: TEVA Country: Israel
  Exchanges: TEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 83,759,043,270
(Year Ending Jan 2017).
Employees: 56,960
  Currency: Israel Shekels Market Cap: 123,930,316,363
  Fiscal Yr Ends: December Shares Outstanding: 1,014,990,306
  Share Type: Ordinary Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.